KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) EBT (2016 - 2025)

Historic EBT for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $7.2 billion.

  • Eli Lilly's EBT rose 35532.61% to $7.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $22.5 billion, marking a year-over-year increase of 12169.94%. This contributed to the annual value of $12.7 billion for FY2024, which is 9345.8% up from last year.
  • Eli Lilly's EBT amounted to $7.2 billion in Q3 2025, which was up 35532.61% from $6.8 billion recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's EBT registered a high of $7.2 billion during Q3 2025, and its lowest value of $427.2 million during Q3 2023.
  • For the 5-year period, Eli Lilly's EBT averaged around $2.6 billion, with its median value being $2.1 billion (2022).
  • As far as peak fluctuations go, Eli Lilly's EBT plummeted by 7271.16% in 2023, and later skyrocketed by 35532.61% in 2025.
  • Over the past 5 years, Eli Lilly's EBT (Quarter) stood at $1.8 billion in 2021, then grew by 13.94% to $2.1 billion in 2022, then grew by 19.67% to $2.5 billion in 2023, then surged by 100.84% to $5.0 billion in 2024, then skyrocketed by 43.54% to $7.2 billion in 2025.
  • Its last three reported values are $7.2 billion in Q3 2025, $6.8 billion for Q2 2025, and $3.5 billion during Q1 2025.